SC-41930 inhibits neutrophil infiltration of the cavine dermis induced by 12(R)-hydroxyeicosatetraenoic acid
Psoriasis is a disease state characterized by epidermal proliferation, neutrophil infiltration, along with release of the proinflammatory mediators leukotriene-B 4 (LTB 4) and 12(R)-hydroxyeicosatetraenoic acid [12(R)-HETE]. LTB 4 and 12(R)-HETE are chemoattractant to the neutrophil, the latter appr...
Saved in:
Published in | Prostaglandins, leukotrienes and essential fatty acids Vol. 38; no. 3; pp. 169 - 172 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
Kidlington
Elsevier Ltd
01.12.1989
Elsevier |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Psoriasis is a disease state characterized by epidermal proliferation, neutrophil infiltration, along with release of the proinflammatory mediators leukotriene-B
4 (LTB
4) and 12(R)-hydroxyeicosatetraenoic acid [12(R)-HETE]. LTB
4 and 12(R)-HETE are chemoattractant to the neutrophil, the latter approximately 1000X less potent. LTB
4 and 12(R)-HETE are present in psoriatic scale, the latter in quantities so much greater than LTB
4 that it is proposed as a primary mediator of neutrophil infiltration in psoriasis. 12(R)-HETE, synthesized in optically pure form by a new, shorter route, was injected into the cavine dermis. At a dose of 25 μgm per intradermal site, 12(R)-HETE was a significant chemoattractant to the neutrophil (as assessed by dermal myeloperoxidase levels). SC-41930, 7-[3-(4-acetyl-3-methoxy-2-propylphenoxy)-propoxy]-3,4-dihydro-8-propyl-2H-1-benzopyran-2-carboxylic acid, given intragastrically inhibited 12(R)-HETE-induced neutrophil infiltration of the cavine dermis with an ED
50 value of 13.5 mg/kg. Compounds such as SC-41930 may well have utility for treating human psoriasis. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 0952-3278 1532-2823 |
DOI: | 10.1016/0952-3278(89)90067-7 |